← Back to Search

Neuromodulation

Low-Intensity Focused Ultrasound for Clinical Follow-up

N/A

Waitlist Available

Research Sponsored by Virginia Polytechnic Institute and State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up outcomes assessed throughout participation - an average of 3 weeks.

Awards & highlights

Study Summary

This trialexamines the effects of brain stimulation on muscle contractions to help improve addiction, pain and mental health. Participants have imaging scans and brain stimulation to temporarily affect activity. EMG records the muscle contractions.

Who is the study for?

This trial is for English-speaking individuals willing to use a medication monitoring system. It's not suitable for those with pacemakers, metal implants, history of significant head injury or substance dependence, active CNS-affecting medical conditions, pregnancy, or claustrophobia.Check my eligibility

What is being tested?

The study tests how different durations of Low-Intensity Focused Ultrasound (LIFU) affect muscle contractions. Participants will undergo brain imaging and stimulation techniques while their muscle responses are recorded.See study design

What are the potential side effects?

Potential side effects may include discomfort from the ultrasound device, temporary changes in brain activity that could influence mood or cognition, and possible skin irritation at the site of ultrasound application.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ outcomes assessed throughout participation - an average of 3 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~outcomes assessed throughout participation - an average of 3 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and outcomes assessed throughout participation - an average of 3 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Waveforms

Trial Design

1Treatment groups

Experimental Treatment

Group I: Duration TrialsExperimental Treatment1 Intervention

Six different durations (three intermittent and three continuous) of LIFU application will be tested across six study sessions. Response recorded using TMS and EMG.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Low-Intensity Focused Ultrasound

2020

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Virginia Polytechnic Institute and State UniversityLead Sponsor

143 Previous Clinical Trials

27,733 Total Patients Enrolled

Media Library

Low-Intensity Focused Ultrasound (Neuromodulation) Clinical Trial Eligibility Overview. Trial Name: NCT05147103 — N/A

Long-term Intensive Follow-up for Clinical Purposes Research Study Groups: Duration Trials

Long-term Intensive Follow-up for Clinical Purposes Clinical Trial 2023: Low-Intensity Focused Ultrasound Highlights & Side Effects. Trial Name: NCT05147103 — N/A

Low-Intensity Focused Ultrasound (Neuromodulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05147103 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does my profile qualify me for inclusion in this experiment?

"This study requires patients to be of legal age and have had a diagnosis in order to participate. Approximately 80 individuals will take part, with the upper limit of 65 years old being strictly enforced."

Answered by AI

Are there any open slots for participants in this investigation?

"According to clinicaltrials.gov, this trial is not actively recruiting patients as of October 11th 2022. Initially posted on August 26th 2022, there are two other medical studies that presently have open enrolment opportunities."

Answered by AI